Pricing Log in Create free account
Saturday 17 October 2026 Export AMGN’s income statement to Excel — free account

Amgen Inc.

AMGN Healthcare Drug Manufacturers General

Amgen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.8 billion, up 9.95% from fiscal 2024. In the quarter to June 2026, revenue grew 9.53%, EPS grew 65.4%, free cash flow grew 82.6% and total debt rose 1.96%, each against the same quarter a year earlier. Member of the S&P 500, Nasdaq 100 and Dow Jones; dividend growth for ten consecutive years, revenue growth for five.

432.49 1.54 −0.35%
Market cap
$234.7B
P/E
26.7×
Fwd P/E
22.7×
Dividend yield
2.30%
F-score
7/9
Altman Z
1.69
Beneish M
−2.27
Dividend safety
56/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Amgen Inc. (AMGN) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, Amgen Inc. (AMGN) trades at a P/B ratio of 20.0×. Over the past ten years it has ranged from 3.3× (November 2016) to 154× (May 2022); the current reading is higher than 70% of that period. That is above the Drug Manufacturers General industry median of 5.0× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 20.3× (14.60%)
FY2024 23.8× (6.72%)
FY2023 25.5× (33.60%)
FY2022 38.5× 100.90%
FY2021 19.1× 33.66%
FY2020 14.3× (5.03%)
FY2019 15.1× 46.47%
FY2018 10.3× 100.82%
FY2017 5.1× 35.83%
FY2016 3.8× (13.87%)

Quarterly newest first

Period P/B ratio Change
Jun 2026 16.7× (19.08%)
Mar 2026 20.7× 1.65%
Dec 2025 20.3× 28.86%
Sep 2025 15.8× (21.95%)
42 more quarters

Against its own ten years

Low 3.3× High 154×
Ten-year median 14.3×
Current reading's percentile 68

P/B ratio against peers

Company P/B ratio
ABBV AbbVie Inc. compare n/m
PFE Pfizer Inc. compare 2.0×
NVO Novo Nordisk A/S compare 5.0×
AZN AstraZeneca PLC compare 5.1×
BMY Bristol Myers Squibb Company compare 5.5×
NVS Novartis AG compare 6.8×
MRK Merck & Co., Inc. compare 8.6×
GILD Gilead Sciences, Inc. compare 16.5×
AMGN Amgen Inc. 20.0×
Drug Manufacturers General industry median 5.0×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on AMGN